论文信息 - Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study. - 字舞流文

Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study.

J. Gathe | R. Trinh | T. Podsadecki | J. Reynes | F. Pulido | R. Qaqish | A. Nilius | L. Fredrick | M. Norton | R. Soto‐malave | M. Tian